Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

29 oct. 2020 16h36 HE | Source: Idera Pharmaceuticals, Inc.

Idera Pharmaceuticals Reports Third Quarter Financial Results and Provides Corporate Update

EXTON, Pa., Oct. 29, 2020 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (“Idera” or the “Company”) (Nasdaq: IDRA) today reported its financial and operational results for the third quarter ended...
28 sept. 2020 08h45 HE | Source: Idera Pharmaceuticals, Inc.

Idera Pharmaceuticals Announces New U.S. Patent Coverage for Tilsotolimod Through September 2037

EXTON, Pa., Sept. 28, 2020 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (Nasdaq: IDRA) today announced that the U.S. Patent and Trademark Office has issued U.S. Patent No. 10,772,907 (the ‘907...